Khavinson short peptide bioregulator (brain-targeted)
Pinealon
Research use only
Written by pep4U Editorial Team · Last reviewed July 8, 2026
A short synthetic tripeptide (Glu-Asp-Arg) from the Khavinson bioregulator family researched for cognitive and central nervous system support.
| Class / type | Khavinson short peptide bioregulator (brain-targeted) |
|---|
| Category | Cognitive & Nootropic |
|---|
| Status (Jul 2026) | Research use only |
|---|
How it works
It is proposed to act as an epigenetic regulator that penetrates cells and neurons and modulates gene expression influencing neuronal function, antioxidant defense, and stress-response pathways.
Known / used for
Researched for cognitive function, neuroprotection, circadian and stress regulation, and age-related brain decline.
Positives
Russian research reports antioxidant and neuroprotective effects and improved cognitive markers in animal and observational models; short peptide reported as well tolerated.
Negatives & risks
Supporting evidence is largely Russian and preclinical, with a lack of rigorous Western clinical trials; human efficacy unproven; unregulated sourcing and purity concerns.
What people like most (reported community sentiment - not endorsement)
Users report subjective improvements in mental sharpness and sleep, but sentiment is anecdotal.
Frequently asked questions
What is Pinealon?
A short synthetic tripeptide (Glu-Asp-Arg) from the Khavinson bioregulator family researched for cognitive and central nervous system support. It is proposed to act as an epigenetic regulator that penetrates cells and neurons and modulates gene expression influencing neuronal function, antioxidant defense, and stress-response pathways.
What is Pinealon used or researched for?
Researched for cognitive function, neuroprotection, circadian and stress regulation, and age-related brain decline.
Is Pinealon FDA-approved or legal?
NOT FDA-approved and not recognized as a drug in the United States; available only as an unregulated research or supplement-grade compound.
What are the main risks or downsides of Pinealon?
Supporting evidence is largely Russian and preclinical, with a lack of rigorous Western clinical trials; human efficacy unproven; unregulated sourcing and purity concerns.
Legal / regulatory status
NOT FDA-approved and not recognized as a drug in the United States; available only as an unregulated research or supplement-grade compound.
Recommended supplies
See all supplies →As an Amazon Associate we earn from qualifying purchases.
← Back to Cognitive & Nootropic